Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...
The full 12-team playoff was revealed Sunday, with the top four seeds earning first-round byes, and eight teams scheduled to play in the first-round at campus sites. We wrap up the first round of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results